Researchers have developed a technique that could open up new ways to facilitate targeted drug delivery into the brain, enabling drugs to treat brain diseases more focally. They used transcranial, focused ultrasound and intravenously injected microbubbles into the blood-brain barrier (BBB) to make a localized, transient opening that allows drugs to cross through the BBB reversibly and noninvasively.